This time it’s all about patients and pharma. What impact is the Covid-19 pandemic having on treatments and trials? Are there some positive ripple effects? Clare hears from Diarmaid Macdonald of Just Treatment- a patient led campaigning organisation and from Dr Olivia Ashman, Pfizer’s UK Oncology Director.

Covid, Cancer and Pharma

This is about the ripple effects that come in the wake of big decisions or events. The current pandemic is having a dreadful effect on everyone but there is one group of vulnerable people it’s hitting particularly hard. Cancer patients. How can they cope when they don’t know if/ when they’ll get their treatment? Are they being pushed to the back of the queue? What else can the NHS do as it is struggling to cope with this unprecedented crisis? I’ll be asking some of the people involved.

Share Covid, Cancer and Pharma

Sign up to save your podcasts

Covid, Cancer and Pharma

Covid, Cancer and Pharma